Hypertension: Biomarkers Clarify Heart Failure Risk - Takeaways - MDSpire

Hypertension: Biomarkers Clarify Heart Failure Risk

Cardiac biomarkers help stratify heart failure risk among patients with prediabetes and hypertension.

  • By

  • Kathryn Wighton

  • February 23, 2026

  • 4 min

Share

  • 1

    Adults with hypertension, prediabetes, and myocardial injury have over five times the heart failure risk compared to those with normoglycemia.

  • 2

    Prediabetes alone, without elevated biomarkers, is not independently linked to increased heart failure risk.

  • 3

    The study involved 8,234 hypertensive participants, measuring high-sensitivity cardiac troponin I and NT-proBNP levels.

  • 4

    A 25% increase in hs-cTnI or NT-proBNP in prediabetic patients significantly raises heart failure risk.

  • 5

    The observational study highlights prediabetes as a modifier of heart failure risk in patients with myocardial dysfunction.

Original Source(s)

Hypertension: Biomarkers Clarify Heart Failure Risk

  • by Kathryn Wighton

  • February 23, 2026

Related Content

Case Report: Persistent fifth aortic arch with coarctation and fourth aortic arch interruption causing infant heart failure – the prenatal and postnatal echocardiographic course

Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study

Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis